Clinical Trial Update: PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) [Phase 2]

View source ↗

Summary

Phase 2 dose-finding and combination development trial of delpazolid for pulmonary tuberculosis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• delpazolid (delpazolid)

Snippet

Sponsor: LigaChem Biosciences, Inc. | Conditions: Infections and Infestations, Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2024-10-28